Lista de obras -

Anal metastasis from breast cancer: a case report and review of the literature.

artículo científico

Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis

scientific article published on 25 June 2019

COVID-19 and cancer care: what do international guidelines say?

artículo científico publicado en 2020

Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance.

artículo científico

Coexistence of two different mutations in codon 12 of the Kras gene in colorectal cancer: Report of a case supporting the concept of tumoral heterogeneity.

artículo científico publicado en 2013

Contractile Reserve As a Marker of Preclinical Cardiotoxicity ⬇️

artículo científico publicado el 15 de noviembre de 2010

Crizotinib-induced cardiotoxicity: the importance of a proactive monitoring and management.

artículo científico

Evaluation of molecular prognostic and predictive factors: an important step towards personalised treatment in non small cell lung cancer ⬇️

artículo científico publicado el 2 de junio de 2011

Focus on maintenance therapy in non-small-cell lung cancer.

artículo científico publicado en 2015

Is there a role for immunotherapy in malignant pleural mesothelioma?

artículo científico publicado en 2018

Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases compared.

artículo científico publicado en 2017

Long-term survival in small cell lung cancer: a case report and review of the literature.

artículo científico publicado en 2014

Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/erlotinib and to ALK inhibitor crizotinib.

artículo científico publicado en 2013

Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer

artículo científico publicado en 2017

Monitoring and Characterization of Circulating Tumor Cells (CTCs) in a Patient With EML4-ALK-Positive Non-Small Cell Lung Cancer (NSCLC).

artículo científico publicado en 2016

New cancer drugs: the Italian unsatisfactory solution

artículo científico publicado en 2014

Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.

artículo científico

Oral anticancer therapy project: Clinical utility of a specific home care nursing programme on behalf of Italian Association of Medical Oncology (AIOM)

artículo científico publicado en 2019

Pemetrexed in Heavily Pretreated Non-Small-Cell Lung Cancer Patients: Case Report and Review of the Literature ⬇️

artículo científico publicado el 1 de diciembre de 2010

Possible applications of circulating tumor cells in patients with non small cell lung cancer.

artículo científico publicado en 2016

Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study.

artículo científico publicado en 2016

Progress and challenges in the treatment of small cell lung cancer

artículo científico publicado en 2017

Reflections about off-label use of anticancer drugs

scientific article published on 01 October 2012

Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published data ⬇️

artículo científico publicado el 1 de abril de 2003

Somatostatin Analog Therapy in Small Cell Lung Cancer

artículo científico publicado en 2016

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: What Do We Know? ⬇️

artículo científico publicado el 1 de diciembre de 2010

The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy.

artículo científico

The clinical impact of a cardiologic follow-up in breast cancer survivors: an observational study.

artículo científico publicado en 2010

The era of a "liquid biopsy" may be on the horizon in non-small cell lung cancer.

artículo científico publicado en 2017

When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugs.

artículo científico publicado en 2015

Which tyrosine kinase inhibitor should be recommended as initial treatment for non-small cell lung cancer patients with EGFR mutations?

artículo científico publicado en 2014

Lista de obras de

Anal metastasis from breast cancer: a case report and review of the literature.

Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis

COVID-19 and cancer care: what do international guidelines say?

Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance.

Coexistence of two different mutations in codon 12 of the Kras gene in colorectal cancer: Report of a case supporting the concept of tumoral heterogeneity.

Contractile Reserve As a Marker of Preclinical Cardiotoxicity ⬇️

Crizotinib-induced cardiotoxicity: the importance of a proactive monitoring and management.

Evaluation of molecular prognostic and predictive factors: an important step towards personalised treatment in non small cell lung cancer ⬇️

Focus on maintenance therapy in non-small-cell lung cancer.

Is there a role for immunotherapy in malignant pleural mesothelioma?

Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases compared.

Long-term survival in small cell lung cancer: a case report and review of the literature.

Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/erlotinib and to ALK inhibitor crizotinib.

Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer

Monitoring and Characterization of Circulating Tumor Cells (CTCs) in a Patient With EML4-ALK-Positive Non-Small Cell Lung Cancer (NSCLC).

New cancer drugs: the Italian unsatisfactory solution

Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.

Oral anticancer therapy project: Clinical utility of a specific home care nursing programme on behalf of Italian Association of Medical Oncology (AIOM)

Pemetrexed in Heavily Pretreated Non-Small-Cell Lung Cancer Patients: Case Report and Review of the Literature ⬇️

Possible applications of circulating tumor cells in patients with non small cell lung cancer.

Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study.

Progress and challenges in the treatment of small cell lung cancer

Reflections about off-label use of anticancer drugs

Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published data ⬇️

Somatostatin Analog Therapy in Small Cell Lung Cancer

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: What Do We Know? ⬇️

The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy.

The clinical impact of a cardiologic follow-up in breast cancer survivors: an observational study.

The era of a "liquid biopsy" may be on the horizon in non-small cell lung cancer.

When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugs.

Which tyrosine kinase inhibitor should be recommended as initial treatment for non-small cell lung cancer patients with EGFR mutations?